NASDAQ:LOXO - Loxo Oncology, Inc.
$234.66
 $0.00
0.00%
2:15PM EDT
2019-02-15
Loxo Oncology, Inc. is a biopharmaceutical company. The Company is focused on development of medicines for patients with genetically defined cancers. The Company's pipeline focuses on cancers that are dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. Larotrectinib, formerly referred to as LOXO-101, is an oral, selective inhibitor of the tropomyosin receptor kinase (TRK) family in development for the treatment of tumors with TRK fusions. TRK fusions have been implicated in various tumor types, such as lung cancer, head and neck cancer, melanoma, colorectal cancer, sarcoma, and breast cancer. LOXO-195 is a drug candidate in preclinical development. It was designed as a second-generation TRK inhibitor intended to address predicted acquired resistance mechanisms resulting from therapy with a first-generation TRK inhibitor, such as larotrectinib, or multikinase inhibitors with anti-TRK activity. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  LOXO     avg for
industry  
  avg for
sector  
42 stocks weight:  80. 09   0. 01   3. 19  
42 stocks rank:  2. 08 K 2. 01 K 1. 09 K
# analyst opinions:  9. 00   14. 84   14. 43  
mean recommendation:  2. 40   1. 91   1. 90  

quick ratio:  3. 58   5. 33   1. 80  
current ratio:  3. 62   5. 64   2. 19  

target price low:  185. 00   89. 87   116. 44  
target price avg:  225. 00   116. 13   140. 62  
target price high:  235. 00   144. 13   161. 60  
1-yr high:  234. 75   124. 91   142. 18  
last close:  234. 50   101. 33   125. 34  
50-day avg:  185. 26   98. 45   122. 34  
200-day avg:  168. 91   99. 87   122. 31  
1-yr low:  100. 92   77. 93   99. 86  
volume:  824. 52 K 2. 40 M 4. 39 M
50-day avg volume:  1. 13 M 3. 29 M 4. 86 M
200-day avg volume:  594. 06 K 3. 21 M 4. 16 M

1-day return:  0. 03 % 0. 35 % -0. 08 %
this week return:  0. 03 % 0. 46 % -0. 07 %
12-wk return:  53. 01 % 5. 59 % 1. 56 %
52-wk return:  149. 67 % -0. 88 % 14. 91 %

enterprise value (EV):  6. 56 B 54. 52 B 102. 18 B
market cap:  7. 21 B 48. 30 B 93. 12 B
EBITDA:  -72. 44 M 4. 78 B 7. 07 B
enterprise multiple (EV/EBITDA):  -90. 53   -88. 47   2. 58  
enterprise/revenue (EV/R):  45. 29   30. 50   23. 55  
total revenue:  144. 80 M 11. 17 B 39. 03 B
total debt:  0. 00   13. 63 B 16. 46 B
net income (common):  -62. 98 M 2. 34 B 3. 51 B

shares outstanding:  30. 75 M 601. 87 M 1. 19 B
shares:  27. 36 M 599. 22 M 1. 12 B
shares short:  1. 06 M 11. 51 M 12. 17 M
shares short prior month:  2. 30 M 11. 81 M 13. 15 M
short ratio:  0. 58   4. 63   2. 90  
short % of float:  4. 85 % 6. 17 % 2. 78 %
total cash/share:  20. 32   12. 23   11. 30  
total cash:  622. 00 M 7. 42 B 7. 19 B
free cash flow:  143. 59 M 94. 45 M 2. 03 B
operating cash flow:  234. 30 M 161. 90 M 3. 01 B

book value:  12. 41   14. 36   28. 94  
price/book:  18. 90   -1. 54   -2. 98  
gross profits:  -118. 74 M 8. 20 B 15. 98 B
operating margins:  -50. 33 % -468. 22 % -616. 90 %
EBITDA margins:  -50. 03 % 13. 04 % 22. 45 %
profit margins:  -43. 49 % 6. 01 % 9. 83 %
gross margins:  -11. 32 % 48. 26 % 54. 52 %

1-yr max volatility:  66. 33 % --- ---
1-yr mean volatility:  0. 48 % 0. 02 % 0. 07 %

1-yr EPS:  -2. 09   2. 91   4. 09  
forward EPS:  -3. 38   4. 19   6. 88  
P/E:  -112. 31   4. 76   27. 05  
forward P/E:  -69. 36   7. 25   10. 02  
PE/G:  142. 92   1. 60   5. 54  
growth:  -0. 79 % 630. 40 % 97. 64 %
earnings high:  -0. 04   1. 24   1. 63  
earnings avg:  -0. 81   0. 98   1. 51  
earnings low:  -1. 23   0. 73   1. 38  
revenue high:  99. 25 M 2. 84 B 10. 79 B
revenue avg:  57. 78 M 2. 75 B 10. 45 B
revenue low:  45. 40 M 2. 64 B 10. 25 B
return on assets:  -8. 51 % -3. 52 % 3. 78 %
return on equity:  -16. 29 % 105. 21 % 25. 65 %
revenue/share:  4. 80   14. 46   58. 94  

beta (1yr vs S&P500):  1. 66   1. 22   0. 94  
sharpe (1yr):  1. 46   0. 20   1. 02  

held % insiders:  4. 12 % 6. 52 % 3. 28 %
held % institutions:  98. 96 % 79. 51 % 70. 64 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-11 : LOXO
.   + 13.225 =        13.225 :: INITIAL WEIGHT
.   + 51.742 =        64.967 :: inverse volume-to-price addition
.  + 147.442 =       212.409 :: spline projection addition
.   + 814.51 =      1026.919 :: notable performance addition
.   - 104.26 =       922.659 :: poor performance penalty
.    x 2.543 =      2345.912 :: one-year gains+dividend factor
.    x 6.294 =     14764.875 :: 13 weeks' performance factor
.    x 1.494 =     22052.663 :: industry recommendation factor
.    x 1.408 =     31046.754 :: symbol recommendation factor
.    x 1.515 =     47033.546 :: EV/R factor
.    x 0.999 =      46993.53 :: return on assets factor
.    x 0.998 =     46916.982 :: return on equity factor
.    x 2.641 =    123922.297 :: current ratio factor
.    x 1.178 =     145983.79 :: quick ratio factor
.    x 1.729 =    252375.888 :: short ratio factor
.    x 2.345 =    591919.822 :: price-to-book factor
.    x 1.389 =    822012.302 :: 5-day avg > 200-day avg
.    x 1.266 =   1040802.167 :: 5-day avg > 50-day avg
.    x 1.097 =   1141546.878 :: 50-day avg > 200-day avg
.    x 2.082 =   2377137.995 :: P/E weight
.    x 0.289 =     687516.15 :: PE/G factor
.    x 1.487 =    1022466.06 :: beta factor
.    x 1.458 =   1490501.404 :: sharpe factor
.    x 0.954 =   1422021.433 :: target low factor
.    x 0.964 =   1371290.663 :: target mean factor
.    x 1.005 =   1377622.695 :: target high factor
.    x 1.056 =   1454618.098 :: industry 12-weeks return
.      x 1.0 =   1454358.087 :: overall "drift" factor
.    x 0.337 =    489638.395 :: largest single-day jump factor
.     x 1.01 =    494511.049 :: mean volatility factor
.    x 1.097 =    542604.483 :: 42-day mean volatility factor
.      x 1.0 =     542636.08 :: factor hist industry gain for week 06
.   cubeRoot =        81.565 :: reduced for readability
.                     81.565 :: FINAL WEIGHT for NASDAQ:LOXO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org